Trial Profile
A study evaluating effect of everolimus on perfusional parameters in pancreatic neuroendocrine tumour patients with liver metastases
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Oct 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Liver metastases; Neuroendocrine tumours; Pancreatic cancer
- Focus Therapeutic Use
- 10 Oct 2017 New trial record